AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34344121 — intervention group
Group type: EXPERIMENTAL
Intervention: Compound wild chrysanthemum eye masks
Number of subjects: 112
Study 34344121 — intervention group
Group type: COMPARATOR
Intervention: Eye mask simulator (control)
Number of subjects: 112
Study 33097092 — intervention group
Group type: COMPARATOR
Intervention: FEC → Doc
Number of subjects: 3754
Study 33097092 — intervention group
Group type: EXPERIMENTAL
Intervention: FEC → Doc/Gem
Number of subjects: 3754
Study 35834777 — intervention group
Group type: EXPERIMENTAL
Intervention: Active maintenance olaparib (300 mg twice daily)
Number of subjects: 154
Study 35834777 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 154
Study 34158381 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher genetically predicted serum magnesium concentrations
Number of subjects: 79429
Study 32745703 — intervention group
Group type: EXPERIMENTAL
Intervention: COPE-P intervention
Number of subjects: 384
Study 32745703 — intervention group
Group type: COMPARATOR
Intervention: Attention control program
Number of subjects: 384
Study 34552422 — intervention group
Group type: EXPERIMENTAL
Intervention: Forearm tourniquet for 25 minutes
Number of subjects: 66
Study 34552422 — intervention group
Group type: COMPARATOR
Intervention: Upper arm tourniquet for 25 minutes
Number of subjects: 66
Study 34552422 — intervention group
Group type: EXPERIMENTAL
Intervention: Forearm tourniquet with immediate deflation (<25 minutes)
Number of subjects: 66
Study 32340906 — intervention group
Group type: EXPERIMENTAL
Intervention: IANB with angulated needle approach (ANA)
Number of subjects: 90
Study 32340906 — intervention group
Group type: COMPARATOR
Intervention: Indirect IANB
Number of subjects: 90
Study 32340906 — intervention group
Group type: COMPARATOR
Intervention: Direct IANB
Number of subjects: 90
Study 35122549 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole adjunctive to periodontal surgery
Number of subjects: 0
Study 35122549 — intervention group
Group type: COMPARATOR
Intervention: Placebo adjunctive to periodontal surgery
Number of subjects: 0
Study 34791813 — intervention group
Group type: EXPERIMENTAL
Intervention: DEX 40 mg on days 1-4 of a 4-week cycle for six cycles
Number of subjects: 8
Study 34791813 — intervention group
Group type: EXPERIMENTAL
Intervention: DEX 40 mg on days 1-4 of a 4-week cycle for six cycles with ruxolitinib 15 mg BID on days 1-21 of each cycle
Number of subjects: 8
Study 34791813 — intervention group
Group type: COMPARATOR
Intervention: Control group (DEX alone)
Number of subjects: 8
Study 36349498 — intervention group
Group type: EXPERIMENTAL
Intervention: Provider Education + Community Health Worker Support (PE+CHW)
Number of subjects: 1010
Study 36349498 — intervention group
Group type: COMPARATOR
Intervention: Provider Education alone (PE)
Number of subjects: 1010
Study 34446487 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal intervention delivered by cancer exercise specialists (CES) for 6 months, including physical activity, basic dietary advice, and psychological support
Number of subjects: 1050
Study 34446487 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal intervention delivered by CES
Number of subjects: 1050
Study 33077895 — intervention group
Group type: EXPERIMENTAL
Intervention: Elamipretide (40 mg per day)
Number of subjects: 12
Study 33077895 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 36221362 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertonic sodium lactate infusion
Number of subjects: 50
Study 36221362 — intervention group
Group type: COMPARATOR
Intervention: Mannitol (conventional group)
Number of subjects: 50
Study 32891977 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Motivational Intervention (BMI)
Number of subjects: 596
Study 32891977 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI with Telephone Booster (BMI + B)
Number of subjects: 596
Study 32891977 — intervention group
Group type: COMPARATOR
Intervention: Brief Advice (BA)
Number of subjects: 596
Study 32771018 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidimensional physical activity feedback using a customised digital system and web-app for 3 months plus five health trainer-led sessions.
Number of subjects: 204
Study 32771018 — intervention group
Group type: COMPARATOR
Intervention: Standardised information regarding physical activity (received by all participants).
Number of subjects: 204
Study 34285011 — intervention group
Group type: EXPERIMENTAL
Intervention: Aflatoxin exposure (measured by AF-albumin adduct levels)
Number of subjects: 374
Study 34285011 — intervention group
Group type: COMPARATOR
Intervention: Control (no specific intervention mentioned)
Number of subjects: 374
Study 33660379 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized education on self-management (50-min session, one telephone counselling after 8 weeks, maintenance of a self-management diary for 12 weeks)
Number of subjects: 60
Study 33660379 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 60
Study 32788268 — intervention group
Group type: EXPERIMENTAL
Intervention: Early feeding (unrestricted diet)
Number of subjects: 33
Study 32788268 — intervention group
Group type: COMPARATOR
Intervention: Initial fasting and intravenous fluids (control)
Number of subjects: 33
Study 32788268 — intervention group
Group type: EXPERIMENTAL
Intervention: Early feeding
Number of subjects: 33
Study 35696725 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonrestricted low‐fat diet (LFD)
Number of subjects: 0
Study 35696725 — intervention group
Group type: EXPERIMENTAL
Intervention: Calorie-restricted (CR) regimens (low‐fat CR, Mediterranean‐style CR, intermittent CR)
Number of subjects: 0
Study 35696725 — intervention group
Group type: COMPARATOR
Intervention: Continuously obese mice
Number of subjects: 0
Study 35696725 — intervention group
Group type: COMPARATOR
Intervention: Lean control mice
Number of subjects: 0
Study 33794664 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical ketorolac tromethamine 0.5%
Number of subjects: 33
Study 33794664 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 32893392 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dialysate [Na+] levels
Number of subjects: 0
Study 32893392 — intervention group
Group type: COMPARATOR
Intervention: Standard dialysate [Na+] levels
Number of subjects: 0
Study 35251940 — intervention group
Group type: EXPERIMENTAL
Intervention: App-based intervention with human guidance
Number of subjects: 356
Study 35251940 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual plus app-based intervention after the active study phase (waitlist control/TAU group)
Number of subjects: 356
Study 32537847 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramucirumab 8 mg/kg on days 1 and 15 and merestinib 80 mg once daily (QD; 28-day cycle)
Number of subjects: 16
Study 32537847 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 16
Study 32773628 — intervention group
Group type: EXPERIMENTAL
Intervention: Retrocolic reconstruction
Number of subjects: 212
Study 32773628 — intervention group
Group type: COMPARATOR
Intervention: Antecolic reconstruction
Number of subjects: 212
Study 32773628 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 212
Study 32203691 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam
Number of subjects: 462
Study 32203691 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosphenytoin
Number of subjects: 462
Study 32203691 — intervention group
Group type: EXPERIMENTAL
Intervention: Valproate
Number of subjects: 462
Study 32203691 — intervention group
Group type: COMPARATOR
Intervention: Levetiracetam, Fosphenytoin, Valproate
Number of subjects: 462
Study 35138568 — intervention group
Group type: COMPARATOR
Intervention: SRP alone (group 1)
Number of subjects: 80
Study 35138568 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP+low‐level laser therapy (LLLT) with Nd:YAG laser (group 2)
Number of subjects: 80
Study 35138568 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP+pocket debridement with Nd:YAG laser (group 3)
Number of subjects: 80
Study 35138568 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP+combined pocket debridement and LLLT with Nd:YAG laser (group 4)
Number of subjects: 80
Study 32965593 — intervention group
Group type: EXPERIMENTAL
Intervention: Active (real) tRNS
Number of subjects: 10
Study 32965593 — intervention group
Group type: COMPARATOR
Intervention: Sham tRNS
Number of subjects: 10
Study 36071624 — intervention group
Group type: EXPERIMENTAL
Intervention: Video call group (VCG: standard care + video call)
Number of subjects: 72
Study 36071624 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG: standard care)
Number of subjects: 72
Study 33098716 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhinitis in the last 12 months
Number of subjects: 1700
Study 33098716 — intervention group
Group type: EXPERIMENTAL
Intervention: Allergic conjunctivitis in the last 12 months
Number of subjects: 1700
Study 33098716 — intervention group
Group type: EXPERIMENTAL
Intervention: Eczema in the last 12 months
Number of subjects: 1700
Study 32854824 — intervention group
Group type: EXPERIMENTAL
Intervention: Back-support exoskeletons (BSEs)
Number of subjects: 18
Study 34697249 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% arterial occlusion pressure
Number of subjects: 22
Study 34697249 — intervention group
Group type: COMPARATOR
Intervention: 150% arterial occlusion pressure
Number of subjects: 22
Study 33723015 — intervention group
Group type: EXPERIMENTAL
Intervention: Recovery of LVEF at 4 months
Number of subjects: 932
Study 33723015 — intervention group
Group type: EXPERIMENTAL
Intervention: Recovery of LVEF at 2 years
Number of subjects: 932
Study 33066856 — intervention group
Group type: EXPERIMENTAL
Intervention: Turmacin 0.5 g
Number of subjects: 90
Study 33066856 — intervention group
Group type: EXPERIMENTAL
Intervention: Turmacin 1 g
Number of subjects: 90
Study 33066856 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 33356569 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal pain regimen (pregabalin, celecoxib, acetaminophen, regional block with oxycodone for breakthrough pain)
Number of subjects: 42
Study 33356569 — intervention group
Group type: COMPARATOR
Intervention: Conventional pain management (regional block, acetaminophen, oxycodone)
Number of subjects: 42
Study 33356569 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal pain regimen
Number of subjects: 42
Study 33356569 — intervention group
Group type: COMPARATOR
Intervention: Conventional pain management
Number of subjects: 42
Study 35644038 — intervention group
Group type: EXPERIMENTAL
Intervention: Family based treatments (FBTs)
Number of subjects: 0
Study 35644038 — intervention group
Group type: COMPARATOR
Intervention: Standard intervention
Number of subjects: 0
Study 34948702 — intervention group
Group type: EXPERIMENTAL
Intervention: Rigid surface group (RsG)
Number of subjects: 17
Study 34948702 — intervention group
Group type: EXPERIMENTAL
Intervention: Sand surface group (SsG)
Number of subjects: 17
Study 35061644 — intervention group
Group type: EXPERIMENTAL
Intervention: Oblique-type superior pubic ramus fractures
Number of subjects: 10
Study 35061644 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior-only and combined anterior and posterior fixation configurations
Number of subjects: 10
Study 35061644 — intervention group
Group type: COMPARATOR
Intervention: Transverse-type fractures
Number of subjects: 10
Study 33010766 — intervention group
Group type: EXPERIMENTAL
Intervention: Trochlear resurfacing with HemiCAP® PF Classic implant
Number of subjects: 60
Study 33010766 — intervention group
Group type: COMPARATOR
Intervention: Medial UKA without trochlear resurfacing
Number of subjects: 60
Study 34994291 — intervention group
Group type: EXPERIMENTAL
Intervention: Demonstration method
Number of subjects: 90
Study 34994291 — intervention group
Group type: COMPARATOR
Intervention: Verbal training
Number of subjects: 90
Study 34994291 — intervention group
Group type: COMPARATOR
Intervention: Training with written materials
Number of subjects: 90
Study 36175532 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified nasopharyngeal oxygen therapy (Group Naso)
Number of subjects: 84
Study 36175532 — intervention group
Group type: COMPARATOR
Intervention: High-flow nasal oxygen therapy (Group HFNO)
Number of subjects: 84
Study 33454393 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial photodynamic therapy (aPDT) with routine oral hygiene maintenance instructions (OHMI)
Number of subjects: 0
Study 33454393 — intervention group
Group type: COMPARATOR
Intervention: Routine oral hygiene maintenance instructions (OHMI) alone
Number of subjects: 0
Study 32164702 — intervention group
Group type: EXPERIMENTAL
Intervention: WP + HMB
Number of subjects: 16
Study 32164702 — intervention group
Group type: COMPARATOR
Intervention: WP + PLA
Number of subjects: 16
Study 35410799 — intervention group
Group type: EXPERIMENTAL
Intervention: 7 Tesla MRI
Number of subjects: 7
Study 35410799 — intervention group
Group type: COMPARATOR
Intervention: 3 Tesla MRI
Number of subjects: 7
Study 33761206 — intervention group
Group type: EXPERIMENTAL
Intervention: ALVAC-HIV vaccine regimen (2704 participants)
Number of subjects: 5404
Study 33761206 — intervention group
Group type: COMPARATOR
Intervention: Placebo (2700 participants)
Number of subjects: 5404
Study 35056316 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal Cord Stimulation (SCS)
Number of subjects: 66
Study 35056316 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorsal Root Ganglion Stimulation (DRGS)
Number of subjects: 66
Study 35056316 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of SCS and DRGS (SCS+DRGS)
Number of subjects: 66
Study 35056316 — intervention group
Group type: EXPERIMENTAL
Intervention: Tonic conventional stimulation
Number of subjects: 66
Study 32704082 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional support plus green-banana biomass (40 g) (n=21)
Number of subjects: 39
Study 33400390 — intervention group
Group type: EXPERIMENTAL
Intervention: UC-MSC treatment (100 ± 20 × 10^6 UC-MSCs, two intravenous infusions at day 0 and 3)
Number of subjects: 24
Study 33400390 — intervention group
Group type: EXPERIMENTAL
Intervention: UC-MSC treatment
Number of subjects: 24
Study 33400390 — intervention group
Group type: COMPARATOR
Intervention: Control (vehicle solution, two infusions)
Number of subjects: 24
Study 33038504 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitated extinction (FE) intervention
Number of subjects: 208
Study 33038504 — intervention group
Group type: COMPARATOR
Intervention: Standard (cognitive-behavioral) intervention
Number of subjects: 208
Study 33038504 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate transition to very low nicotine content (VLNC) cigarettes
Number of subjects: 208
Study 33038504 — intervention group
Group type: EXPERIMENTAL
Intervention: Gradual transition to very low nicotine content (VLNC) cigarettes
Number of subjects: 208
Study 35711442 — intervention group
Group type: EXPERIMENTAL
Intervention: bivalent Oral Poliovirus Vaccine (bOPV)
Number of subjects: 1115
Study 35711442 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1115
Study 33550679 — intervention group
Group type: EXPERIMENTAL
Intervention: Preparation for the TSST‐M alone
Number of subjects: 180
Study 33550679 — intervention group
Group type: EXPERIMENTAL
Intervention: Preparation for the TSST‐M with a parent
Number of subjects: 180
Study 33550679 — intervention group
Group type: COMPARATOR
Intervention: No-stress control group
Number of subjects: 180
Study 32114186 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced treatment (5 worksites; n = 50 participants)
Number of subjects: 97
Study 32114186 — intervention group
Group type: COMPARATOR
Intervention: Minimal treatment (3 worksites; n = 47 participants)
Number of subjects: 97
Study 32114186 — intervention group
Group type: EXPERIMENTAL
Intervention: Both enhanced and minimal treatment
Number of subjects: 97
Study 32114186 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced treatment
Number of subjects: 97
Study 32114186 — intervention group
Group type: COMPARATOR
Intervention: Minimal treatment
Number of subjects: 97
Study 36463145 — intervention group
Group type: EXPERIMENTAL
Intervention: Piezosurgery assisted osteotomy
Number of subjects: 12
Study 36463145 — intervention group
Group type: COMPARATOR
Intervention: Conventional drills
Number of subjects: 12
Study 34337726 — intervention group
Group type: EXPERIMENTAL
Intervention: Parecoxib 40 mg IV 30 min before surgery and then 40 mg IV every 12 h for the initial 48 h postoperatively (n=20)
Number of subjects: 40
Study 34337726 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline, n=20)
Number of subjects: 40
Study 33371755 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A: Urinary bladders transected cranial to the ureteral papillae and concomitantly omentalized
Number of subjects: 9
Study 33371755 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B: Omentalization two weeks prior to vesicle creation
Number of subjects: 9
Study 33371755 — intervention group
Group type: EXPERIMENTAL
Intervention: Group C: Neoureterocystostomy and omentalization followed by neoreservoir formation and tube cystostomy 2 weeks later
Number of subjects: 9
Study 32030695 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibrating tourniquet applied
Number of subjects: 90
Study 32030695 — intervention group
Group type: COMPARATOR
Intervention: No vibrating tourniquet applied (control)
Number of subjects: 90
Study 35711611 — intervention group
Group type: EXPERIMENTAL
Intervention: ERAS program
Number of subjects: 646
Study 35711611 — intervention group
Group type: COMPARATOR
Intervention: Traditional group
Number of subjects: 646
Study 34423039 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV testing services
Number of subjects: 277
Study 34423039 — intervention group
Group type: COMPARATOR
Intervention: Completed primary education
Number of subjects: 277
Study 34423039 — intervention group
Group type: COMPARATOR
Intervention: Employment status
Number of subjects: 277
Study 34423039 — intervention group
Group type: COMPARATOR
Intervention: Condom use in last sexual intercourse
Number of subjects: 277
Study 34423039 — intervention group
Group type: COMPARATOR
Intervention: Involvement in HIV testing outreaches
Number of subjects: 277
Study 33164085 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular percutaneous electrical nerve field stimulation (PENFS)
Number of subjects: 21
Study 33164085 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (ST)
Number of subjects: 21
Study 33213459 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutri-Score
Number of subjects: 12391
Study 33213459 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple Traffic Lights
Number of subjects: 12391
Study 33213459 — intervention group
Group type: COMPARATOR
Intervention: Reference Intakes
Number of subjects: 12391
Study 33213459 — intervention group
Group type: EXPERIMENTAL
Intervention: Warning symbols
Number of subjects: 12391
Study 33213459 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Star Rating system
Number of subjects: 12391
Study 33340845 — intervention group
Group type: EXPERIMENTAL
Intervention: External focus training
Number of subjects: 75
Study 33340845 — intervention group
Group type: COMPARATOR
Intervention: Internal focus training
Number of subjects: 75
Study 33340845 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 75
Study 32315553 — intervention group
Group type: EXPERIMENTAL
Intervention: Wii-Fit training at home for additional 8 weeks
Number of subjects: 40
Study 32315553 — intervention group
Group type: COMPARATOR
Intervention: Habitual activity during the 8-week follow-up
Number of subjects: 40
Study 35997619 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management program (8 sessions)
Number of subjects: 70
Study 35997619 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 70
Study 34618601 — intervention group
Group type: COMPARATOR
Intervention: Ibrutinib
Number of subjects: 164
Study 34618601 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibrutinib plus Venetoclax
Number of subjects: 164
Study 34618601 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 164
Study 32307641 — intervention group
Group type: EXPERIMENTAL
Intervention: Fine-needle aspiration cytology (FNAC)
Number of subjects: 314
Study 32307641 — intervention group
Group type: COMPARATOR
Intervention: Watchful observation
Number of subjects: 314
Study 33945983 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback-informed treatment (FIT)
Number of subjects: 2233
Study 33945983 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2233
Study 32305659 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness session
Number of subjects: 80
Study 32305659 — intervention group
Group type: COMPARATOR
Intervention: Mind wandering (control condition)
Number of subjects: 80
Study 32305659 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness and Mind wandering (both groups)
Number of subjects: 80
Study 32560970 — intervention group
Group type: EXPERIMENTAL
Intervention: Freeze-only ET
Number of subjects: 391
Study 32560970 — intervention group
Group type: COMPARATOR
Intervention: Fresh ET
Number of subjects: 391
Study 35325562 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote telemonitoring (RTM) using an interactive bidirectional system (Motiva®)
Number of subjects: 621
Study 35325562 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SoC)
Number of subjects: 621
Study 35325562 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote telemonitoring (RTM)
Number of subjects: 621
Study 32386407 — intervention group
Group type: COMPARATOR
Intervention: Stepped-wedge cluster randomized trial (SW-CRT)
Number of subjects: 0
Study 32386407 — intervention group
Group type: COMPARATOR
Intervention: Conventional parallel cluster randomized trial (parallel-CRT)
Number of subjects: 0
Study 35407572 — intervention group
Group type: EXPERIMENTAL
Intervention: Mosapride SR 15 mg combined with esomeprazole 20 mg once daily (ME group)
Number of subjects: 60
Study 35407572 — intervention group
Group type: COMPARATOR
Intervention: Esomeprazole 20 mg once daily alone (E group)
Number of subjects: 60
Study 33201741 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-activation tools (3-minute video and 1-page checklist) delivered electronically 1 week, 3 days, and 24 hours prior to clinic visit
Number of subjects: 306
Study 33201741 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 306
Study 35761406 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SoC)
Number of subjects: 0
Study 35761406 — intervention group
Group type: EXPERIMENTAL
Intervention: Valganciclovir
Number of subjects: 0